Geode Capital Management, LLC Bristol Myers Squibb CO Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Geode Capital Management, LLC holds 41,304,605 shares of BMY stock, worth $1.7 Billion. This represents 0.21% of its overall portfolio holdings.

Number of Shares

41,304,605

Previous 39,677,105 4.1%

Holding current value

$1.7 Billion

Previous $2.04 Billion 10.03%

% of portfolio

0.21%

Previous 0.22%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $78.1 Million - $88.5 Million	1,627,500 Added 4.1%	41,304,605 $2.24 Billion
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $1.26 Million - $1.5 Million	-25,942 Reduced 0.07%	39,677,105 $2.04 Billion
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $38.7 Million - $43.3 Million	668,706 Added 1.71%	39,703,047 $2.3 Billion
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $14.3 Million - $15.9 Million	225,065 Added 0.58%	39,034,341 $2.5 Billion
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $5.6 Million - $6.35 Million	85,162 Added 0.22%	38,809,276 $2.69 Billion

Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $29 Million - $34.3 Million	-423,021 Reduced 1.08%	38,724,114 $2.78 Billion
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $147,069 - $86.9 Million	1,131,303 Added 2.98%	39,147,135 $2.78 Billion
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $33 Million - $36.3 Million	454,368 Added 1.21%	38,015,832 $2.92 Billion
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $18.5 Million - $22.2 Million	-301,635 Reduced 0.8%	37,561,464 $2.74 Billion
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $49.5 Million - $57.7 Million	922,811 Added 2.5%	37,863,099 $2.35 Billion
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $58.1 Million - $68.1 Million	982,470 Added 2.73%	36,940,288 $2.18 Billion
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $83.9 Million - $91.3 Million	1,354,869 Added 3.92%	35,957,818 $2.4 Billion
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $34.2 Million - $38.4 Million	575,652 Added 1.69%	34,602,949 $2.18 Billion
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $17.2 Million - $19.5 Million	297,655 Added 0.88%	34,027,297 $2.11 Billion
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $44.4 Million - $49.1 Million	772,282 Added 2.34%	33,729,642 $2.03 Billion
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $399 Million - $466 Million	-7,276,641 Reduced 18.09%	32,957,360 $1.93 Billion
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $83.3 Million - $121 Million	1,796,244 Added 4.67%	40,234,001 $2.24 Billion
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $542 Million - $707 Million	11,012,994 Added 40.16%	38,437,757 $2.46 Billion
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $74.4 Million - $88.2 Million	1,738,638 Added 6.77%	27,424,763 $1.39 Billion
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $67.9 Million - $75.1 Million	1,522,093 Added 6.3%	25,686,125 $1.16 Billion
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $174 Million - $207 Million	3,847,693 Added 18.94%	24,164,032 $1.15 Billion
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $9.58 Million - $12.4 Million	-196,511 Reduced 0.96%	20,316,339 $1.05 Billion
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $18.6 Million - $21 Million	337,536 Added 1.67%	20,512,850 $1.27 Billion
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $19.6 Million - $24.5 Million	388,721 Added 1.96%	20,175,314 $1.11 Billion
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $72.1 Million - $83 Million	1,203,124 Added 6.47%	19,786,593 $1.25 Billion
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $46.6 Million - $50.8 Million	777,929 Added 4.37%	18,583,469 $1.14 Billion
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $18.7 Million - $21.6 Million	338,317 Added 1.94%	17,805,540 $1.13 Billion
Q2 2017 Aug 14, 2017	BUY	N/A	17,467,223	17,467,223 $972 Million

Others Institutions Holding BMY

# of Institutions

2,552

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $87.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Bristol Myers Squibb CO Transaction History